TW200724140A - Hydantoin compounds - Google Patents

Hydantoin compounds

Info

Publication number
TW200724140A
TW200724140A TW095118533A TW95118533A TW200724140A TW 200724140 A TW200724140 A TW 200724140A TW 095118533 A TW095118533 A TW 095118533A TW 95118533 A TW95118533 A TW 95118533A TW 200724140 A TW200724140 A TW 200724140A
Authority
TW
Taiwan
Prior art keywords
hydantoin compounds
hydantoin
compounds
treating
relates
Prior art date
Application number
TW095118533A
Other languages
English (en)
Inventor
Eric Carlson
Qian Chen
Heather Davis
Brian M Gallagher Jr
Shawn Schiller
Christina Shaffer
Mark Spyvee
Nancy Wong
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of TW200724140A publication Critical patent/TW200724140A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW095118533A 2005-05-27 2006-05-25 Hydantoin compounds TW200724140A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68559405P 2005-05-27 2005-05-27

Publications (1)

Publication Number Publication Date
TW200724140A true TW200724140A (en) 2007-07-01

Family

ID=37189015

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095118533A TW200724140A (en) 2005-05-27 2006-05-25 Hydantoin compounds

Country Status (15)

Country Link
US (2) US7666875B2 (zh)
EP (2) EP1888583A2 (zh)
JP (1) JP2008542304A (zh)
KR (1) KR20080013931A (zh)
CN (1) CN101263141A (zh)
AU (1) AU2006251947A1 (zh)
BR (1) BRPI0609895A2 (zh)
CA (1) CA2609270A1 (zh)
DE (1) DE06771541T1 (zh)
IL (1) IL187279A0 (zh)
MX (1) MX2007014888A (zh)
NO (1) NO20076515L (zh)
RU (1) RU2007149327A (zh)
TW (1) TW200724140A (zh)
WO (1) WO2006128143A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds
CA2651454A1 (en) * 2006-05-26 2007-12-06 Eisai R&D Management Co., Ltd. Imidazoazephinone compounds
WO2007139948A2 (en) * 2006-05-26 2007-12-06 Eisai R & D Management Co., Ltd Imidazoazepinone compounds
ES2347837T3 (es) 2006-05-26 2010-11-04 EISAI R&D MANAGEMENT CO., LTD. Compuestos de imidazoazefinona.
EP2063889A4 (en) * 2006-09-07 2009-09-16 Merck & Co Inc SPIROPIPERIDINE BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
WO2009064431A1 (en) * 2007-11-15 2009-05-22 Eisai E & D Management Co., Ltd. Methods of use
CN101889014A (zh) * 2007-11-15 2010-11-17 卫材R&D管理有限公司 富含对映体的咪唑并吖庚因酮化合物
JP2011504878A (ja) * 2007-11-26 2011-02-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 イミダゾアゼピノン化合物の製造方法
US10696668B2 (en) 2016-02-25 2020-06-30 Asceneuron Sa Acid addition salts of piperazine derivatives
AU2017222958B2 (en) 2016-02-25 2019-07-18 Asceneuron S. A. Glycosidase inhibitors
US11795165B2 (en) 2018-08-22 2023-10-24 Asceneuron Sa Tetrahydro-benzoazepine glycosidase inhibitors
US11731972B2 (en) * 2018-08-22 2023-08-22 Asceneuron Sa Spiro compounds as glycosidase inhibitors
WO2024092040A1 (en) * 2022-10-26 2024-05-02 Protego Biopharma, Inc. Spirocycle containing bicyclic heteroaryl compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US685594A (en) 1901-04-19 1901-10-29 Frank A Franklin Pulp-washing machine.
WO2004092169A1 (ja) * 2003-04-18 2004-10-28 Ono Pharmaceutical Co., Ltd. スピロピペリジン化合物およびその医薬用途
CA2579609A1 (en) * 2003-09-10 2005-03-17 Virochem Pharma Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
WO2006000096A1 (en) * 2004-06-25 2006-01-05 Virochem Pharma Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds

Also Published As

Publication number Publication date
CN101263141A (zh) 2008-09-10
US20100113446A1 (en) 2010-05-06
WO2006128143A3 (en) 2007-03-29
US7666875B2 (en) 2010-02-23
KR20080013931A (ko) 2008-02-13
IL187279A0 (en) 2008-02-09
NO20076515L (no) 2007-12-19
EP1888583A2 (en) 2008-02-20
AU2006251947A1 (en) 2006-11-30
WO2006128143A2 (en) 2006-11-30
CA2609270A1 (en) 2006-11-30
BRPI0609895A2 (pt) 2011-10-11
US20060270696A1 (en) 2006-11-30
JP2008542304A (ja) 2008-11-27
DE06771541T1 (de) 2008-09-11
EP2336131A1 (en) 2011-06-22
MX2007014888A (es) 2008-02-19
RU2007149327A (ru) 2009-07-10

Similar Documents

Publication Publication Date Title
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
TW200724140A (en) Hydantoin compounds
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
IL197080A0 (en) Pyrimidone compounds as gsk-3 inhibitors
WO2007079214A3 (en) Prokineticin 2 receptor antagonists
EA201070238A1 (ru) Соединения пиримидина
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
MX2009005712A (es) Antagonistas de receptor de orexina de diazepam sustituido.
DE602007008434D1 (de) Rezeptoren
MX2009006339A (es) Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide.
JO2355B1 (en) Hereditary calcitonin polypeptide receptor antagonists
TW200640924A (en) VEGF-R2 inhibitors and methods
TNSN07161A1 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
PL1910338T3 (pl) Związki heterotetracykliczne jako mimetyki TPO
EP1861399A4 (en) CGRP RECEPTOR ANTAGONISTS
GB0510143D0 (en) Novel compounds A1
WO2009016253A3 (en) Cyanomethyl substituted n-acyl tryptamines
EA201070423A1 (ru) Диарильные соединения оксадиазолов
WO2003105840A3 (en) SPHINGOSINE KINASE INHIBITORS
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
UA100974C2 (ru) Соединения замещенных диазепанов как антагонисты орексиновых рецепторов
MX2008002166A (es) Compuestos y composiciones como mimeticos de trombopoietina (tpo).
RS20080246A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
JO2747B1 (en) Vehicles
IN2015DN03331A (zh)